Sort
326,823 grants matching “clinical trial”
PACT
$2,297,550Adrian Philip Gee · Baylor College Of Medicine · N01 · FY2011 · HL
Studies of Childhood Solid Tumors
$2,297,459Linda M Hendershot · St. Jude Children'S Research Hospital · P01 · FY2010 · CA
Translational Studies in FLASH Particle Radiotherapy
$2,297,298Constantinos Koumenis · University Of Pennsylvania · P01 · FY2024 · CA
CHEMISTRY AND BIOLOGY OF HEPARAN SULFATE
$2,297,262Umesh Ramanlal Desai · Virginia Commonwealth University · P01 · FY2017 · HL
Genetic and Signaling Pathways in Epithelial Thyroid Cancer
$2,297,243Matthew D Ringel · Ohio State University · P01 · FY2017 · CA
Preventive Vaccines for HIV
$2,297,148Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Stem Cell Biology: New Directions in Clinical and Basic Research
$2,297,137Peter J Quesenberry · Rhode Island Hospital · P20 · FY2011 · RR
Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance
$2,296,936Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2017 · CA
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma
$2,296,647Laura Beretta · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Advancing brain health research through male germline editing in marmosets
$2,296,544Brian Peter Hermann · University Of Texas San Antonio · U01 · FY2024 · DA
Comprehensive multimodal analysis of patients with neuroimmunological diseases
$2,296,246Bibiana Bielekova · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Lung Vascular Disease in Infants and Children: Mechanisms and Treatment
$2,296,239Kurt R Stenmark · University Of Colorado Denver · P50 · FY2008 · HL
Pacific Ovarian Cancer Research Consortium
$2,296,158Nicole D. Urban · Fred Hutchinson Cancer Research Center · P50 · FY2012 · CA
The CSBC Research Center for Cancer Systems Immunology at MSKCC
$2,296,097Christina S Leslie · Sloan-Kettering Inst Can Research · U54 · FY2019 · CA
Synergies among inhibitory receptors in tolerance, cancer & antiviral immunity
$2,296,071Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2021 · AI
Columbia Collaborative HIV/AIDS Clinical Trials Unit
$2,296,028Scott M Hammer · Columbia University Health Sciences · U01 · FY2011 · AI
Glucose homeostasis and the risk of Alzheimer's disease and Alzheimer's disease related dementias in the Multi-Ethnic Study of Atherosclerosis
$2,295,981Morgana Lee Mongraw-Chaffin · Wake Forest University Health Sciences · RF1 · FY2021 · AG
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT)
$2,295,742Abhijit Prakash Limaye · University Of Washington · U01 · FY2021 · AI
Molecular and Clinical Manifestations of Matrix and Aggregate Myopathies
$2,295,629Carsten Bonnemann · National Institute Of Neurological Disorders And Stroke · ZIA · FY2013 · NS
Host and Microbial Metabolism in Graft versus Host Disease
$2,295,629Pavan Reddy · University Of Michigan At Ann Arbor · P01 · FY2021 · HL
Pharmacogenetics Research Network and Knowledge Base
$2,295,626Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2005 · GM
Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN PATHS) study
$2,295,461Emily Ai-Hua Wang · Yale University · UG1 · FY2022 · DA
CHEMISTRY AND BIOLOGY OF HEPARAN SULFATE
$2,295,423Umesh Ramanlal Desai · Virginia Commonwealth University · P01 · FY2016 · HL
MIT-Harvard Center of Cancer Nanotechnology Excellence
$2,295,376Robert S Langer · Massachusetts Institute Of Technology · U54 · FY2010 · CA
Neuroblastoma Tumor Microenvironment: tumor growth and immune regulation
$2,295,320Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA